Skip to main content
News Icon

News categories: Honors & Funding

Christian Kurts appointed honorary professor

Prof. Dr. Christian Kurts, Professor of Experimental Immunology at the University of Bonn, has been appointed honorary professor at the Department of Microbiology and Immunology at the University of Melbourne. With this appointment, Australia's leading university acknowledges the achievements in establishing a scientific network between Melbourne and Bonn. Prof. Kurts is a recipient of the Gottfried-Wilhelm-Leibniz-Prize, director of the Institute of Experimental Immunology at the University Hospital Bonn and member of the cluster of Excellence ImmunoSensation.

"The appointment as honorary professor is a great honor for me," says Prof. Kurts. "I hope that the commitment between Bonn and Melbourne will lead to a sustainable, bilateral relationship in teaching and research beyond the already established programs". Further bilateral projects are already in preparation.

Related news

Plastic bottles

News categories: Honors & Funding

Effects of “Forever Chemicals” on the Immune System

Dr. Lorenzo Bonaguro from the German Center of Neurodegenerative Dieseases (DZNE) has been awarded a Starting Grant from the European Research Council (ERC) totaling about 1.5 million euros to investigate the influence of the ubiquitous PFAS chemicals on the immune system. His research will utilize so-called organoids and cutting-edge analysis methods.
View entry
Csm Bradke header 498bf3128b

News categories: Honors & Funding

Berlin-Brandenburg Academy of Science Honors Bonn Neurobiologist

Neurobiologist Frank Bradke, a research group leader at DZNE and professor at the University of Bonn, has been awarded the 50,000 euro Academy Prize of the Berlin-Brandenburg Academy of Sciences and Humanities. The award recognizes his outstanding scientific accomplishments in the field of neuronal development and regeneration. With his studies, the Bonn scientist, who focuses on fundamental mechanisms, aims to pave the way for a better treatment of spinal cord injuries. In recent years, Bradke has already been recognized with several awards for his exceptional research.
View entry
Hoerauf Huebner PM

News categories: Honors & Funding

Award for Drug Research on River Blindness and Elephantiasis

The A∙WOL team has been awarded the Horizon Prize 2024 by the Royal Society of Chemistry for the discovery of potentially fast-acting, highly specific anti-Wolbachia candidates for the oral treatment of human filariasis. The team is a collaboration between the University of Liverpool, the Liverpool School of Tropical Medicine, Imperial College London, the University Hospital Bonn (UKB), and the University of Bonn, as well as industry partners AstraZeneca and Eisai Ltd, funded for many years by the Gates Foundation.
View entry

Back to the news overview